2019
DOI: 10.1016/j.jpba.2019.03.013
|View full text |Cite
|
Sign up to set email alerts
|

Seventeen O-acetylated N-glycans and six O-acetylation sites of Myozyme identified using liquid chromatography-tandem mass spectrometry

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
8
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(13 citation statements)
references
References 28 publications
0
8
0
Order By: Relevance
“…Myozyme (Genzyme) is an alpha-glucosidase employed for enzyme replacement therapy for patients with Pompe disease and has at least 6 confirmed N -glycosylation sites. Both mono- and di- O -acetylated sialic acids have been reported on the N -glycans of Myozyme 47 . Aflibercept (Regeneron) is a fusion protein of the extracellular domain of the human VEGF receptor modified and the Fc region of human IgG1 and used for the treatment of metastatic colorectal cancer.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Myozyme (Genzyme) is an alpha-glucosidase employed for enzyme replacement therapy for patients with Pompe disease and has at least 6 confirmed N -glycosylation sites. Both mono- and di- O -acetylated sialic acids have been reported on the N -glycans of Myozyme 47 . Aflibercept (Regeneron) is a fusion protein of the extracellular domain of the human VEGF receptor modified and the Fc region of human IgG1 and used for the treatment of metastatic colorectal cancer.…”
Section: Resultsmentioning
confidence: 99%
“…Collectively, the results demonstrate that IM-MS can assign both acetyl ester position and sialic acid linkage type of N -glycans released from biologicals using CCS values of B 1 and B 3 fragment ions. Previously, only compositions of O -acetylated structures could be determined by MS showing the presence of mono- and di- O -acetylated sialosides in Myozyme 47 .…”
Section: Resultsmentioning
confidence: 99%
“…Using a similar interpretation method, Park and co-workers demonstrated six O-AcSia sites on recombinant human acid α-glucosidase (Myozyme). 22 The approaches adopted by these two studies, which rely heavily on "expert experience," are difficult to achieve large-scale identification of O-AcSGPs.…”
Section: ■ Introductionmentioning
confidence: 99%
“…Using diagnostic ions for distinguishing different types of sialic acids, Medzihradszky et al identified five O -acetylated O -glycopeptides from Nucleobindin-1 and two O -acetylated N -glycopeptides from Haptoglobin in a mouse. Using a similar interpretation method, Park and co-workers demonstrated six O -AcSia sites on recombinant human acid α-glucosidase (Myozyme) . The approaches adopted by these two studies, which rely heavily on “expert experience,” are difficult to achieve large-scale identification of O -AcSGPs.…”
Section: Introductionmentioning
confidence: 99%
“…The structural characterization of r-hGAA poses a challenge due to the exceptional heterogeneity of the glycan structures (hybrid, complex, and oligomannose type, which may be additionally phosphorylated or acetylated), the different glycan abundances, and the high number of r-hGAA glycosylation sites. Previous studies reported a partial characterization of r-hGAA at the level of released glycans and glycopeptides ( 40 , 41 , 42 , 43 ). In these studies, oligomannose, hybrid-, and complex-type glycan structures were reported also embedding O -acetylation of sialic acids ( 41 ) and phosphorylation of oligomannose structures ( 40 , 41 , 42 , 43 ).…”
mentioning
confidence: 99%